History will mark the twenty-first century as the dawn of the age of precise genetic manipulation. Breakthroughs in genome editing are poised to enable humankind to fundamentally transform life on Earth. Those familiar with genome editing understand its potential to revolutionize civilization in ways that surpass the impact of the discovery of electricity and the development of gunpowder, the atomic bomb, or the Internet. Significant questions regarding how society should promote or hinder genome editing loom large in the horizon. And it is up to humans to decide the fate of this powerful technology. Rewriting Nature is a compelling, thought-provoking interdisciplinary exploration of the law, science, and policy of genome editing. The book guides readers through complex legal, scientific, ethical, political, economic, and social issues concerning this emerging technology, and challenges the conventional false dichotomy often associated with science and law, which contributes to a growing divide between both fields.
Paul Enri quez
Cambridge University Press
Country of Publication:
Publication Date: 24 June 2021
Professional and scholarly
1. A Momentous Time for Humankind; 2. How an Idea Became a Reality; 3. What is Genome Editing?; 4. Molecular Paraphernalia; 5. What Can Genome Editing Be Used For?; 6. Redesigning Food; 7. Regulating Bioengineered Food; 8. Redesigning Humanity; 9. DNA and the Administrative State; 10. Constitutional Predicaments; 11. Science, Law, and Policy; 12. Epilogue.
Paul Enriquez, J.D., LL.M., Ph.D., is an intellectual property attorney and scientist who researches and writes at the intersection of law, science, and policy. He holds doctoral degrees in law and structural and molecular biochemistry. His research on law, science, and technology, genome editing, biochemistry, and the regulation of biotechnology, has been published in numerous scientific, legal, and popular-media publications, and has been presented at national and international conferences. He currently serves as a judicial clerk at the U.S. Court of Appeals for the Federal Circuit.